Announced Mon, 6 Jul · 13:32 IST
Routine quarterly certificate under SEBI depository regulations
Compliance View source PDF
CONCORDBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.9%1-day move
₹1281.80
prior close
₹1279.90
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.0+0.0+0.0+0.1-0.9-1.6+2.3+1.7+5.3+4.8-1.2———
Up moveDown movePending
AI summary
Concord Biotech has submitted to NSE and BSE a certificate dated July 01, 2026 from its Registrar MUFG Intime India, under Regulation 74(5) of SEBI Depositories Regulations for the quarter ended June 30, 2026. The certificate confirms that all share certificates received for dematerialisation during the quarter were processed, and the underlying securities have been listed on the stock exchanges. Mutilated physical certificates were cancelled after verification.
Likely market impact
Routine compliance filing. No impact on shareholders, shareholding pattern, or stock price.